Ignite Creation Date:
2024-10-25 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06531356
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-02-13
Brief Title:
Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population Investigators aim is to know quality of wound healing rate of infection and time needed for complete healing Participants will be divided into two groups All participants will undergo cesarean section We will inject autologous amniotic fluid in the edges of the wound during skin closure in half of the participants Wound healing will be assessed at 1st 2nd and 6th week postoperatively
Detailed Description:
After surgery participants will be observed along 6 weeks at 1 2 and 6 weeks intervals and scars will be assessed regarding color thickness pliability and presence of exudate
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None